全文获取类型
收费全文 | 2805篇 |
免费 | 218篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 160篇 |
妇产科学 | 21篇 |
基础医学 | 527篇 |
口腔科学 | 41篇 |
临床医学 | 268篇 |
内科学 | 577篇 |
皮肤病学 | 18篇 |
神经病学 | 313篇 |
特种医学 | 106篇 |
外科学 | 347篇 |
综合类 | 10篇 |
预防医学 | 191篇 |
眼科学 | 5篇 |
药学 | 170篇 |
中国医学 | 5篇 |
肿瘤学 | 249篇 |
出版年
2024年 | 4篇 |
2023年 | 20篇 |
2022年 | 48篇 |
2021年 | 94篇 |
2020年 | 68篇 |
2019年 | 79篇 |
2018年 | 80篇 |
2017年 | 76篇 |
2016年 | 69篇 |
2015年 | 101篇 |
2014年 | 102篇 |
2013年 | 162篇 |
2012年 | 217篇 |
2011年 | 217篇 |
2010年 | 108篇 |
2009年 | 120篇 |
2008年 | 189篇 |
2007年 | 205篇 |
2006年 | 178篇 |
2005年 | 177篇 |
2004年 | 165篇 |
2003年 | 133篇 |
2002年 | 152篇 |
2001年 | 19篇 |
2000年 | 16篇 |
1999年 | 22篇 |
1998年 | 35篇 |
1997年 | 24篇 |
1996年 | 26篇 |
1995年 | 19篇 |
1994年 | 13篇 |
1993年 | 14篇 |
1992年 | 15篇 |
1991年 | 8篇 |
1990年 | 2篇 |
1989年 | 8篇 |
1988年 | 3篇 |
1987年 | 6篇 |
1986年 | 6篇 |
1985年 | 7篇 |
1984年 | 4篇 |
1983年 | 3篇 |
1982年 | 4篇 |
1981年 | 5篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1975年 | 2篇 |
1974年 | 1篇 |
1973年 | 2篇 |
1971年 | 2篇 |
排序方式: 共有3033条查询结果,搜索用时 78 毫秒
141.
Rex C.‐C. Huang MS Anssi Auvinen PhD Matti Hakama PhD Teuvo L. J. Tammela PhD Martti Ala‐Opas PhD Mikael Leppilahti PhD Timo Vornanen MD Hsiu‐Hsi Chen PhD 《Health expectations》2014,17(6):776-783
Background
Patient preference for the choice of treatment modality for prostate cancer has increasingly gained attention.Objective
To assess the impact of client‐oriented decision on long‐term mortality, disease progression and biochemical failure compared with standard treatment protocol (TP).Methods
With data from a Finnish multicentre, randomized controlled trial with two arms [104 in the enhanced patient participation (EPP) arm and 106 in the TP arm], disease‐specific and disease‐free survival, biochemical failure with elevated prostate‐specific antigen (PSA) level and disease progression were compared between the two arms using Wilcoxon test and also Cox proportional hazards regression model.Results
Patients in the EPP arm had a higher risk of death by 37% [HR, 1.37 (0.87–2.17)] compared with those in the TP arm. Patients in the EPP arm were at increased risk of having biochemical failure by 14% [HR, 1.14 (0.72–1.79)] and for having disease progression by 2% [HR, 1.02 (0.61–1.70)] compared with those in the TP arm. All the differences were non‐significant.Conclusions
Patients actively involved in the choice of treatment had higher risk of prostate cancer death but only slightly increased risk of biochemical failure and clinical disease progression. These findings would provide a good reference when patient autonomy for the choice of treatment modality is addressed. 相似文献142.
143.
144.
Cecilia Dhejne Katarina Öberg Stefan Arver Mikael Landén 《Archives of sexual behavior》2014,43(8):1535-1545
Incidence and prevalence of applications in Sweden for legal and surgical sex reassignment were examined over a 50-year period (1960–2010), including the legal and surgical reversal applications. A total of 767 people (289 natal females and 478 natal males) applied for legal and surgical sex reassignment. Out of these, 89 % (252 female-to-males [FM] and 429 male-to-females [MF]) received a new legal gender and underwent sex reassignment surgery (SRS). A total of 25 individuals (7 natal females and 18 natal males), equaling 3.3 %, were denied a new legal gender and SRS. The remaining withdrew their application, were on a waiting list for surgery, or were granted partial treatment. The incidence of applications was calculated and stratified over four periods between 1972 and 2010. The incidence increased significantly from 0.16 to 0.42/100,000/year (FM) and from 0.23 to 0.73/100,000/year (MF). The most pronounced increase occurred after 2000. The proportion of FM individuals 30 years or older at the time of application remained stable around 30 %. In contrast, the proportion of MF individuals 30 years or older increased from 37 % in the first decade to 60 % in the latter three decades. The point prevalence at December 2010 for individuals who applied for a new legal gender was for FM 1:13,120 and for MF 1:7,750. The FM:MF sex ratio fluctuated but was 1:1.66 for the whole study period. There were 15 (5 MF and 10 MF) regret applications corresponding to a 2.2 % regret rate for both sexes. There was a significant decline of regrets over the time period. 相似文献
145.
Mikael Rostila Jan Saarela Ichiro Kawachi 《Social psychiatry and psychiatric epidemiology》2014,49(6):919-927
Purpose
To study the association between loss of an adult sibling due to suicide and mortality from various causes up to 18 years after bereavement.Methods
We conducted a follow-up study between 1981 and 2002, based on register data representing the total population of Swedes aged 25–64 years (n = 1,748,069).Results
An elevated mortality rate from all causes was found among men (RR 1.26; 95 % CI: 1.14–1.40) and women (1.27; 1.11–1.45) who had experienced a sibling’s suicide. The standardized rate ratio of suicide of bereaved to non-bereaved persons was 2.46 (1.86–3.24) among men and 3.25 (2.28–4.65) among women. We also found some indications of an interrelation between sibling suicide and subsequent deaths from external causes other than suicide in men (1.77; 1.34–2.34) and deaths from cardiovascular disease in women (1.37; 0.99–1.91). An elevated all-cause mortality rate was found after the first year of bereavement in men, while bereaved women experienced higher mortality rates during the first 2 years and after 5 years of bereavement.Conclusions
Our study provides support for adverse health effects among survivors associated with sibling loss due to suicide. Sibling suicides were primarily associated with suicide in bereaved survivors, although there was an increased mortality rate from discordant causes, which strengthens the possibility that the observed associations might not be entirely due to shared genetic causes. 相似文献146.
Milla Valta Ahmad Mahfuz Gazali Tyyne Viisanen Emmi-Leena Ihantola Ilse Ekman Jorma Toppari Mikael Knip Riitta Veijola Jorma Ilonen Johanna Lempainen Tuure Kinnunen 《European journal of immunology》2020,50(4):581-588
Dysfunction of FOXP3-positive regulatory T cells (Tregs) likely plays a major role in the pathogenesis of multiple autoimmune diseases including type 1 diabetes (T1D). Whether genetic polymorphisms associated with the risk of autoimmune diseases affect Treg frequency or function is currently unclear. Here, we analysed the effect of T1D-associated major HLA class II haplotypes and seven single nucleotide polymorphisms in six non-HLA genes [INS (rs689), PTPN22 (rs2476601), IL2RA (rs12722495 and rs2104286), PTPN2 (rs45450798), CTLA4 (rs3087243), and ERBB3 (rs2292239)] on peripheral blood Treg frequencies. These were determined by flow cytometry in 65 subjects who had progressed to T1D, 86 islet autoantibody-positive at-risk subjects, and 215 islet autoantibody-negative healthy controls. The PTPN22 rs2476601 risk allele A was associated with an increase in total (p = 6 × 10−6) and naïve (p = 4 × 10−5) CD4+CD25+CD127lowFOXP3+ Treg frequencies. These findings were validated in a separate cohort comprising ten trios of healthy islet autoantibody-negative children carrying each of the three PTPN22 rs2476601 genotypes AA, AG, and GG (p = 0.005 for total and p = 0.03 for naïve Tregs, respectively). In conclusion, our analysis implicates the autoimmune PTPN22 rs2476601 risk allele A in controlling the frequency of Tregs in human peripheral blood. 相似文献
147.
148.
Andrea Biloglav Linda Olsson‐Arvidsson Johan Theander Mikael Behrendtz Anders Castor Bertil Johansson 《Genes, chromosomes & cancer》2020,59(9):540-543
In recent years, a subgroup of B‐cell precursor acute lymphoblastic leukemia (BCP ALL) without an established abnormality (“B‐other”) has been shown to be characterized by rearrangements of ABL1, ABL2, CSF1R, or PDGFRB (a.k.a. ABL‐class genes). Using FISH with probes for these genes, we screened 55 pediatric and 50 adult B‐other cases. Three (6%) of the adult but none of the childhood B‐other cases were positive for ABL‐class aberrations. RT‐PCR and sequencing confirmed a rare SFPQ‐ABL1 fusion in one adult B‐other case with t(1;9)(p34;q34). Only six SFPQ‐ABL1‐positive BCP ALLs have been reported, present case included. A review of these shows that all harbored fusions between exon 9 of SFPQ and exon 4 of ABL1, that the fusion is typically found in adolescents/younger adults without hyperleukocytosis, and that IKZF1 deletions are recurrent. The few patients not treated with tyrosine kinase inhibitors (TKIs) and/or allogeneic stem cell transplantation relapsed, strengthening the notion that TKI should be added to the therapy of SFPQ‐ABL1‐positive BCP ALL. 相似文献
149.
Lifestyle management is the first line of treatment for moderately elevated blood lipids in healthy individuals. We investigated the effectiveness of providing food-based written advice for lowering low-density lipoprotein (LDL) cholesterol (intervention) or triglycerides (control) in a pragmatic randomized controlled trial with two parallel arms from 2018–2019 at a rural primary health care center. We sent feedback letters after 3 weeks and 6 months. Out of the 113 adult primary care patients randomized, 112 completed the study. There were no differences between the intervention and control groups for changes in LDL cholesterol after 3 weeks (mean ± standard deviation −0.21 ± 0.38 vs. −0.11 ± 0.34 mmol/L, p = 0.45) or 6 months (−0.05 ± 0.47 vs. 0.02 ± 0.41 mmol/L, p = 0.70) (primary outcome). Following the advice to consume plant sterols and turmeric was associated with a reduction in LDL cholesterol after 3 weeks. Following the advice to consume less carbohydrates was associated with reduced triglycerides. In the intervention arm, 14 individuals (25%) reduced their LDL cholesterol by ≥10% after three weeks. Their reduction was attenuated but maintained after six months (−7.1 ± 9.2% or −0.31 ± 0.38 mmol/L, p = 0.01 compared with baseline). They differed only in higher adherence to the advice regarding turmeric. In conclusion, this undemanding intervention had little effect on blood lipids for most individuals. 相似文献
150.
Emma R Veldman Andrea Varrone Katarina Varns Marie M Svedberg Zsolt Cselnyi Mikael Tiger Balzs Gulys Christer Halldin Johan Lundberg 《Journal of cerebral blood flow and metabolism》2022,42(4):630
The serotonin 1B (5-HT1B) receptor has lately received considerable interest in relation to psychiatric and neurological diseases, partly due to findings based on quantification using Positron Emission Tomography (PET). Although the brainstem is an important structure in this regard, PET radioligand binding quantification in brainstem areas often shows poor reliability. This study aims to improve PET quantification of 5-HT1B receptor binding in the brainstem.Volumes of interest (VOIs) were selected based on a 3D [3H]AZ10419369 Autoradiography brainstem model, which visualized 5-HT1B receptor distribution in high resolution. Two previously developed VOI delineation methods were tested and compared to a conventional manual method. For a method based on template data, a [11C]AZ10419369 PET template was created by averaging parametric binding potential (BPND) images of 52 healthy subjects. VOIs were generated based on a predefined volume and BPND thresholding and subsequently applied to test-retest [11C]AZ10419369 parametric BPND images of 8 healthy subjects. For a method based on individual subject data, VOIs were generated directly on each individual parametric image.Both methods showed improved reliability compared to a conventional manual VOI. The VOIs created with [11C]AZ10419369 template data can be automatically applied to future PET studies measuring 5-HT1B receptor binding in the brainstem. 相似文献